SCHEMBL19923458

SCHEMBL19923458

CC1(C)C(=O)N([Si](C)(C)C)C(=O)N1c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.38
ELANE P08246 2/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
DHFR P00374 2/20 0.36
ALDH1A1 P00352 4/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
LMNA P02545 1/20 0.35
PGR P06401 1/20 0.35
AR P10275 2/20 0.34
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923676 0.83 GRM4 (0.45) GRM4SMN1; SMN2ELANECACNA1BAPBA1
SCHEMBL19923459 0.82 GRM4 (0.41) GRM4SMN1; SMN2ELANEDHFRALDH1A1
SCHEMBL19923499 0.82 ALDH1A1 (0.37) GRM4SMN1; SMN2ELANECACNA1BAPBA1
SCHEMBL19923675 0.81 GRM4 (0.40) GRM4SMN1; SMN2ELANEDHFRALDH1A1
SCHEMBL19923699 0.80 HTR1A (0.35) GRM4ELANECACNA1BAPBA1ALDH1A1
SCHEMBL19923449 0.79 ELANE (0.44) ELANEALDH1A1CYP2C19LMNA
SCHEMBL14945821 0.79 GRM4 (0.46) GRM4SMN1; SMN2ELANECACNA1BAPBA1
SCHEMBL19923441 0.77 GRM4 (0.57) GRM4ELANECACNA1BAPBA1ALDH1A1
SCHEMBL19923633 0.75 ELANE (0.41) ELANECYP2C19LMNAMEN1KMT2A
SCHEMBL19923521 0.72 ELANE (0.47) ELANEALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN GRM4 2257/4885SMN1; SMN2 1697/4885ELANE 1249/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM GRM4 2114/4885SMN1; SMN2 1924/4885ELANE 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.